Felix Memenga

ORCID: 0000-0003-4511-8048
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Cardiovascular Function and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Heart rate and cardiovascular health
  • Heart Failure Treatment and Management
  • Animal Virus Infections Studies
  • Cardiac Imaging and Diagnostics
  • Trauma and Emergency Care Studies
  • Cardiac Arrest and Resuscitation
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • SARS-CoV-2 and COVID-19 Research
  • Heart Rate Variability and Autonomic Control
  • Cardiac Arrhythmias and Treatments
  • Transplantation: Methods and Outcomes
  • Cardiac Structural Anomalies and Repair

University Medical Center Hamburg-Eppendorf
2023

Universität Hamburg
2023

Abstract Aims Whether sex affects selection for and outcomes after heart transplantation (HTx) remains unclear. We aimed to show differences in pre‐transplant characteristics HTx. Methods results From 1995 2019, 49 200 HTx recipients were prospectively enrolled the Organ Procurement Transplantation Network. Logistic regression models used evaluate clinical by sex. Multivariable Cox fitted assess all‐cause mortality, cardiovascular graft failure, cardiac allograft vasculopathy (CAV),...

10.1002/ehf2.14413 article EN cc-by-nc-nd ESC Heart Failure 2023-06-20

Achieving early rhythm control and maintaining sinus are associated with improved outcomes in patients atrial fibrillation (AF). Pulmonary vein isolation (PVI) is a validated alternative to medical control. This study determined associations between left strain reservoir (LAS

10.1253/circj.cj-24-0209 article EN Circulation Journal 2024-06-04

Among heart transplant (HT) recipients, a reduced immunological response to SARS-CoV-2 vaccination has been reported. We aimed assess the humoral and T-cell in HT recipients understand determinants of immunogenicity. were prospectively enrolled from January 2021 until March 2022. Anti-SARS-CoV-2-Spike IgG levels quantified after two three doses vaccine (BNT162b2, mRNA1273, or AZD1222). Spike-specific responses assessed using flow cytometry. Ninety-one patients included study (69% male,...

10.3389/ti.2023.10883 article EN cc-by Transplant International 2023-02-06

Abstract Aims For patients with symptomatic drug-refractory atrial fibrillation (AF), catheter ablation to achieve rhythm control is an important therapeutic option. The mechanical dispersion measured as standard deviation of the time peak strain (SD-TPS) associated risk AF recurrence following ablation. Methods study cohort prospectively enrolled n = 132 consecutive paroxysmal ( 88) or persistent 44) presenting for de novo pulmonary vein isolation (PVI) and followed 1 year. We related left...

10.1007/s00392-024-02435-0 article EN cc-by Clinical Research in Cardiology 2024-05-21

Aim. Pharmacologic reduction in heart rate with beta-blockers (BB) or ivabradine is associated improved survival failure (HF) sinus rhythm. We analyzed the association of different rate-reducing drug treatments on outcomes HF outpatients. Methods. Consecutive patients rhythm referred to a specialized tertiary service were prospectively enrolled from August 2015 until March 2018. Clinical characteristics assessed at baseline. performed Cox regression analyses examine effect resting and...

10.3390/jcm12216779 article EN Journal of Clinical Medicine 2023-10-26

Abstract Aim Pharmacologic reduction of heart rate (HR) with beta blockers (BB) and/or ivabradine has been associated improved survival in patients failure (HF) sinus rhythm. We analyzed the impact different HR-reducing drug treatments on outcomes a cohort outpatients (HF). Methods Consecutive HF and rhythm (SR) referred to specialized tertiary service offering advanced therapy options including assist device transplantation were prospectively enrolled from August 2015 until March 2018....

10.1093/eurheartj/ehad655.977 article EN European Heart Journal 2023-11-01
Coming Soon ...